GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » NovMetaPharma Co Ltd (XKRX:229500) » Definitions » Cash Flow for Lease Financing

NovMetaPharma Co (XKRX:229500) Cash Flow for Lease Financing : ₩-139.64 Mil (TTM As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is NovMetaPharma Co Cash Flow for Lease Financing?

NovMetaPharma Co's Cash Flow for Lease Financing for the six months ended in Dec. 2024 was ₩-139.64 Mil. NovMetaPharma Co's Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Dec. 2024 was ₩-139.64 Mil.

Compared with last quarter (₩-119.65 Mil in Dec. 2023 ), NovMetaPharma Co's Cash Flow for Lease Financing remained the same in Dec. 2024 (₩-139.64 Mil).


NovMetaPharma Co Cash Flow for Lease Financing Historical Data

The historical data trend for NovMetaPharma Co's Cash Flow for Lease Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NovMetaPharma Co Cash Flow for Lease Financing Chart

NovMetaPharma Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash Flow for Lease Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -128.89 -116.38 -113.65 -119.65 -139.64

NovMetaPharma Co Semi-Annual Data
Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash Flow for Lease Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only -128.89 -116.38 -113.65 -119.65 -139.64

NovMetaPharma Co Cash Flow for Lease Financing Calculation

Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing.


For stock reported annually, GuruFocus uses latest annual data as the TTM data. Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Dec. 2024 was ₩-139.64 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NovMetaPharma Co Cash Flow for Lease Financing Related Terms

Thank you for viewing the detailed overview of NovMetaPharma Co's Cash Flow for Lease Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


NovMetaPharma Co Business Description

Traded in Other Exchanges
N/A
Address
727 13, Gangnam-gu, Seoul eonju layer, Seoul, KOR
NovMetaPharma Co Ltd researches and develops new medicines and health supplements for metabolic diseases. The company is developing a therapeutic agent that is in Phase 2a clinical trial for Type 2 diabetes and obesity. It also develops therapeutic agents for Alzheimer's disease, immune system diseases, osteoporosis, and non-alcoholic fatty liver diseases.

NovMetaPharma Co Headlines

No Headlines